List of Prevacid Iv drug patents

Prevacid Iv is owned by Takeda Pharms Na.

Prevacid Iv contains Lansoprazole.

Prevacid Iv has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Prevacid Iv are:

  • US7396841*PED

Prevacid Iv was authorised for market use on 27 May, 2004.

Prevacid Iv is available in injectable;intravenous dosage forms.

The generics of Prevacid Iv are possible to be released after 17 February, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7396841

(Pediatric)

TAKEDA PHARMS NA Injections
Feb, 2022

(1 year, 1 month ago)

Drugs and Companies using LANSOPRAZOLE ingredient

Market Authorisation Date: 27 May, 2004

Treatment: NA

Dosage: INJECTABLE;INTRAVENOUS

More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in